Advanced diffusion imaging to track progression in Parkinson’s disease, multiple system atrophy, and progressive supranuclear palsy

[1]  M. Aggarwal,et al.  Microstructural Tissue Changes in a Rat Model of Mild Traumatic Brain Injury , 2021, Frontiers in Neuroscience.

[2]  P. McColgan,et al.  Longitudinal thalamic white and grey matter changes associated with visual hallucinations in Parkinson’s disease , 2021, Journal of Neurology, Neurosurgery, and Psychiatry.

[3]  D. Vaillancourt,et al.  Emerging Neuroimaging Biomarkers Across Disease Stage in Parkinson Disease: A Review. , 2021, JAMA neurology.

[4]  Jiun-Jie Wang,et al.  Fixel-Based Analysis of White Matter Degeneration in Patients With Progressive Supranuclear Palsy or Multiple System Atrophy, as Compared to Parkinson's Disease , 2021, Frontiers in Aging Neuroscience.

[5]  Young T. Hong,et al.  In vivo coupling of dendritic complexity with presynaptic density in primary tauopathies , 2020, Neurobiology of Aging.

[6]  P. McColgan,et al.  Visual dysfunction predicts cognitive impairment and white matter degeneration in Parkinson’s disease , 2020 .

[7]  Tao Guo,et al.  Fixel-based analysis reveals fiber-specific alterations during the progression of Parkinson’s disease , 2020, NeuroImage: Clinical.

[8]  Tanya Simuni,et al.  Neurite orientation dispersion and density imaging (NODDI) and free‐water imaging in Parkinsonism , 2019, Human brain mapping.

[9]  S. Ng,et al.  A longitudinal fixel-based analysis of white matter alterations in patients with Parkinson's disease , 2019, NeuroImage: Clinical.

[10]  Stephen A. Coombes,et al.  Development of a transcallosal tractography template and its application to dementia , 2019, NeuroImage.

[11]  Ajay S. Kurani,et al.  Development and validation of the automated imaging differentiation in parkinsonism (AID-P): a multicentre machine learning study. , 2019, The Lancet. Digital health.

[12]  C. Jack,et al.  MRI Outperforms [18F]AV‐1451 PET as a Longitudinal Biomarker in Progressive Supranuclear Palsy , 2018, Movement disorders : official journal of the Movement Disorder Society.

[13]  D. Vaillancourt,et al.  Imaging of Motor Cortex Physiology in Parkinson's Disease , 2018, Movement disorders : official journal of the Movement Disorder Society.

[14]  Derek B Archer,et al.  A Template and Probabilistic Atlas of the Human Sensorimotor Tracts using Diffusion MRI , 2018, Cerebral cortex.

[15]  Derek B Archer,et al.  A widespread visually-sensitive functional network relates to symptoms in essential tremor , 2018, Brain : a journal of neurology.

[16]  Ofer Pasternak,et al.  Progression marker of Parkinson’s disease: a 4-year multi-site imaging study , 2017, Brain : a journal of neurology.

[17]  Ofer Pasternak,et al.  Free water improves detection of changes in the substantia nigra in parkinsonism: A multisite study , 2017, Movement disorders : official journal of the Movement Disorder Society.

[18]  Murray Grossman,et al.  Clinical diagnosis of progressive supranuclear palsy: The movement disorder society criteria , 2017, Movement disorders : official journal of the Movement Disorder Society.

[19]  Alan Connelly,et al.  Investigating white matter fibre density and morphology using fixel-based analysis , 2017, NeuroImage.

[20]  Jan Sijbers,et al.  Denoising of diffusion MRI using random matrix theory , 2016, NeuroImage.

[21]  Richard J. Binney,et al.  Progression of brain atrophy in PSP and CBS over 6 months and 1 year , 2016, Neurology.

[22]  Nikolaus R. McFarland,et al.  Functional MRI of disease progression in Parkinson disease and atypical parkinsonian syndromes , 2016, Neurology.

[23]  N. Schuff,et al.  Progression of Microstructural Degeneration in Progressive Supranuclear Palsy and Corticobasal Syndrome: A Longitudinal Diffusion Tensor Imaging Study , 2016, PloS one.

[24]  R. Kaji,et al.  The difference of apparent diffusion coefficient in the middle cerebellar peduncle among parkinsonian syndromes: Evidence from a meta-analysis , 2016, Journal of the Neurological Sciences.

[25]  O. Rascol,et al.  Multimodal MRI assessment of nigro‐striatal pathway in multiple system atrophy and Parkinson disease , 2016, Movement disorders : official journal of the Movement Disorder Society.

[26]  Ofer Pasternak,et al.  Free-water imaging in Parkinson's disease and atypical parkinsonism. , 2016, Brain : a journal of neurology.

[27]  Stamatios N. Sotiropoulos,et al.  An integrated approach to correction for off-resonance effects and subject movement in diffusion MR imaging , 2016, NeuroImage.

[28]  Stamatios N. Sotiropoulos,et al.  A probabilistic atlas of the cerebellar white matter , 2016, NeuroImage.

[29]  D. Vaillancourt,et al.  Longitudinal changes in free-water within the substantia nigra of Parkinson's disease. , 2015, Brain : a journal of neurology.

[30]  J. Parisi,et al.  Expanding the spectrum of neuronal pathology in multiple system atrophy. , 2015, Brain : a journal of neurology.

[31]  D. Vaillancourt,et al.  Increased free water in the substantia nigra of Parkinson's disease: a single-site and multi-site study , 2015, Neurobiology of Aging.

[32]  M. Chakravarty,et al.  Functional Consequences of Neurite Orientation Dispersion and Density in Humans across the Adult Lifespan , 2015, The Journal of Neuroscience.

[33]  Jan Sijbers,et al.  Multi-tissue constrained spherical deconvolution for improved analysis of multi-shell diffusion MRI data , 2014, NeuroImage.

[34]  R. Hilker,et al.  The value of putaminal diffusion imaging versus 18‐fluorodeoxyglucose positron emission tomography for the differential diagnosis of the Parkinson variant of multiple system atrophy , 2014, Movement disorders : official journal of the Movement Disorder Society.

[35]  D. Dickson.  Parkinson's disease and parkinsonism: neuropathology. , 2012, Cold Spring Harbor perspectives in medicine.

[36]  Daniel C. Alexander,et al.  NODDI: Practical in vivo neurite orientation dispersion and density imaging of the human brain , 2012, NeuroImage.

[37]  Stuart Crozier,et al.  Apparent Fibre Density: A novel measure for the analysis of diffusion-weighted magnetic resonance images , 2012, NeuroImage.

[38]  S. Fujii,et al.  Significance of apparent diffusion coefficient measurement for the differential diagnosis of multiple system atrophy, progressive supranuclear palsy, and Parkinson's disease: evaluation by 3.0-T MR imaging , 2012, Neuroradiology.

[39]  J. Frank,et al.  The contribution of gliosis to diffusion tensor anisotropy and tractography following traumatic brain injury: validation in the rat using Fourier analysis of stained tissue sections. , 2011, Brain : a journal of neurology.

[40]  Stuart Crozier,et al.  Symmetric diffeomorphic registration of fibre orientation distributions , 2011, NeuroImage.

[41]  N. Intrator,et al.  Free water elimination and mapping from diffusion MRI , 2009, Magnetic resonance in medicine.

[42]  P Sandroni,et al.  Second consensus statement on the diagnosis of multiple system atrophy , 2008, Neurology.

[43]  D. Dickson,et al.  Clinical and neuropathologic features of progressive supranuclear palsy with severe pallido-nigro-luysial degeneration and axonal dystrophy. , 2008, Brain : a journal of neurology.

[44]  Brian B. Avants,et al.  Symmetric diffeomorphic image registration with cross-correlation: Evaluating automated labeling of elderly and neurodegenerative brain , 2008, Medical Image Anal..

[45]  W. Poewe,et al.  Diffusion weighted imaging best discriminates PD from MSA‐P: A comparison with tilt table testing and heart MIBG scintigraphy , 2007, Movement disorders : official journal of the Movement Disorder Society.

[46]  L. Golbe,et al.  A clinical rating scale for progressive supranuclear palsy. , 2007, Brain : a journal of neurology.

[47]  J. Jankovic,et al.  Movement Disorder Society‐sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS‐UPDRS): Process, format, and clinimetric testing plan , 2007, Movement disorders : official journal of the Movement Disorder Society.

[48]  Fumiaki Tanaka,et al.  Usefulness of combined fractional anisotropy and apparent diffusion coefficient values for detection of involvement in multiple system atrophy , 2006, Journal of Neurology, Neurosurgery & Psychiatry.

[49]  Francesco Fera,et al.  Apparent diffusion coefficient measurements of the middle cerebellar peduncle differentiate the Parkinson variant of MSA from Parkinson's disease and progressive supranuclear palsy. , 2006, Brain : a journal of neurology.

[50]  G. Halliday,et al.  A comparison of degeneration in motor thalamus and cortex between progressive supranuclear palsy and Parkinson's disease. , 2005, Brain : a journal of neurology.

[51]  J. Cummings,et al.  The Montreal Cognitive Assessment, MoCA: A Brief Screening Tool For Mild Cognitive Impairment , 2005, Journal of the American Geriatrics Society.

[52]  Mark W. Woolrich,et al.  Advances in functional and structural MR image analysis and implementation as FSL , 2004, NeuroImage.

[53]  Sid Gilman,et al.  Development and validation of the Unified Multiple System Atrophy Rating Scale (UMSARS) , 2004, Movement disorders : official journal of the Movement Disorder Society.

[54]  D W Dickson,et al.  Atrophy of superior cerebellar peduncle in progressive supranuclear palsy , 2003, Neurology.

[55]  H. Braak,et al.  Staging of brain pathology related to sporadic Parkinson’s disease , 2003, Neurobiology of Aging.

[56]  N. Quinn,et al.  Multiple system atrophy: A review of 203 pathologically proven cases , 1997, Movement disorders : official journal of the Movement Disorder Society.

[57]  J. Hughes,et al.  Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases. , 1992, Journal of neurology, neurosurgery, and psychiatry.

[58]  A. Lees,et al.  Ageing and Parkinson's disease: substantia nigra regional selectivity. , 1991, Brain : a journal of neurology.

[59]  H. Arai,et al.  Clinical Diagnosis , 1890, Edinburgh Medical Journal.

[60]  P N Karnauchow,et al.  Accuracy of clinical diagnosis. , 1982, Canadian Medical Association journal.